Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2013 by Instituto Nacional de Cancer, Brazil.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Susanne Crocamo, Instituto Nacional de Cancer, Brazil Identifier:
First received: September 20, 2011
Last updated: March 4, 2013
Last verified: March 2013
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2014
  Estimated Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)